Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
about
Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.Complexation behavior of oppositely charged polyelectrolytes: Effect of charge distribution.Amphiphilic graft copolymer based on poly(styrene-co-maleic anhydride) with low molecular weight polyethylenimine for efficient gene deliveryRecent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.Materials innovation for co-delivery of diverse therapeutic cargos.Functional supramolecular polymers for biomedical applications.Supramolecular cyclodextrin-based drug nanocarriers.Drug and gene co-delivery systems for cancer treatment.Drug-conjugated polymers as gene carriers for synergistic therapeutic effect.Soft Supramolecular Nanoparticles by Noncovalent and Host-Guest Interactions.Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery.Effective cell uptake of nanoassemblies of a fluorescent amphiphilic cyclodextrin and an anionic porphyrin.Advanced materials for co-delivery of drugs and genes in cancer therapy.A supramolecular strategy to assemble multifunctional viral nanoparticles.Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells.Investigation of the Sequential Actions of Doxorubicin and p53 on Tumor Cell Growth Via Branched Polyethylenimine-β-cyclodextrin Conjugates.Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.A selective decoy-doxorubicin complex for targeted co-delivery, STAT3 probing and synergistic anti-cancer effect.Supramolecular nanoparticle carriers self-assembled from cyclodextrin- and adamantane-functionalized polyacrylates for tumor-targeted drug delivery
P2860
Q30913776-D6110692-F86F-401A-BD0F-3C0ED5D0896FQ35646952-E1CFB147-1A1F-4759-AD40-48592425101DQ36247150-CADA969A-1037-4D6A-BFE9-7DDEE15A2E84Q38204933-0F96A41E-10DD-4B98-994E-BD14615C56ACQ38211033-AB9B21FB-9502-4B38-B6AC-7F7A4467EF5CQ38267889-D97EECF6-C8E8-4FD6-A30F-DC451536C93AQ38354545-CBF3C50F-DEDA-4B63-ABFD-BFE5B3371EAEQ38556764-C66F6937-93F0-4D57-88BD-DCE8D8EDED5AQ38608253-C92499FA-C7E6-4A84-B5F4-BE17602D7D9FQ38638661-DB945DA9-E4E4-4EA4-BAF8-895841DA877AQ39117681-62EDDCA3-4DF8-472B-BB69-99576F648755Q39507768-718CE60F-1900-45C3-9591-56BB28270B48Q39513734-E98AC666-5455-475E-9471-E3362FE50FB0Q42270788-C7E5903A-BC6A-44C6-B3C4-10F05DB8052EQ42826162-DEC8F8BF-0503-456D-A0ED-1816CD3E341CQ45885455-2E598AA0-B7FE-4BCD-BD42-431CD1B6F1D0Q47642768-68F3AB0F-1EF8-4EF8-9B48-328631A9B0EFQ50070105-4F3E6064-7300-425B-AB26-38398F243FA7Q51835543-FF50E8B3-A0DC-41BF-80C1-AE72DC4E8636Q57348013-F3EF0C07-1520-4C4B-9C4C-25AA1C7DF5CB
P2860
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
@en
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
@nl
type
label
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
@en
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
@nl
prefLabel
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
@en
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
@nl
P2093
P2860
P356
P1476
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug
@en
P2093
Gu-Ping Tang
Wen-Quan Liang
P2860
P304
P356
10.1039/C1CC10721F
P407
P577
2011-04-06T00:00:00Z